Yifeng Pharmacy Chain Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,018	3,081	3,579	3,566	4,113	2,921
Short-Term Investments	-	163.61	20.52	-	-	-
Trading Asset Securities	6,336	5,854	4,407	1,631	50.05	152.19
Cash & Short-Term Investments	9,354	9,098	8,006	5,197	4,163	3,073
Cash Growth	10.02%	13.64%	54.07%	24.84%	35.46%	-25.22%
Accounts Receivable	1,808	1,985	2,153	2,150	1,846	1,087
Other Receivables	430.91	501.42	477.94	448.54	419.47	323.6
Receivables	2,239	2,486	2,631	2,599	2,265	1,411
Inventory	4,207	4,637	4,528	3,808	3,615	3,041
Prepaid Expenses	-	30.48	37.16	-	-	35.17
Other Current Assets	589.18	573.74	652.9	525.62	535.91	356.71
Total Current Assets	16,388	16,826	15,856	12,129	10,578	7,916
Property, Plant & Equipment	4,569	4,717	5,679	5,665	4,892	4,504
Long-Term Investments	134.81	133.59	530.22	592.97	334.09	6.72
Goodwill	4,766	4,765	4,769	4,611	4,188	3,718
Other Intangible Assets	470.04	480.91	483.09	470.97	478.2	389.25
Long-Term Deferred Tax Assets	124.17	129.54	148.62	138.67	127.68	109.79
Long-Term Deferred Charges	374.23	387.72	493.88	499.14	430.69	379.59
Other Long-Term Assets	8.77	12.25	15.17	30.27	7.23	28.39
Total Assets	26,835	27,452	27,975	24,137	21,036	17,052
Accounts Payable	8,097	8,830	9,492	8,171	6,761	4,806
Accrued Expenses	326.22	632.01	587.26	549.68	683.11	390
Short-Term Debt	-	-	30.03	-	-	-
Current Portion of Long-Term Debt	1,081	7.46	66	103.48	92.92	4.21
Current Portion of Leases	-	1,141	1,271	1,355	1,185	931.44
Current Income Taxes Payable	409.73	301.88	207.1	165.76	176.87	148.83
Current Unearned Revenue	195.31	228.52	130.07	80.17	60.69	41.1
Other Current Liabilities	547.95	612.08	814.24	844.45	700.13	424.11
Total Current Liabilities	10,657	11,753	12,598	11,269	9,659	6,745
Long-Term Debt	1,664	1,651	1,601	133.62	228.67	365.65
Long-Term Leases	1,531	1,605	2,313	2,206	1,951	2,024
Long-Term Unearned Revenue	53.08	53.19	53.63	54.09	54.69	50.34
Long-Term Deferred Tax Liabilities	10.34	11.35	15.41	26.76	23.71	2.16
Total Liabilities	13,916	15,073	16,581	13,689	11,917	9,187
Common Stock	1,212	1,212	1,212	1,011	721.7	718.77
Additional Paid-In Capital	3,651	3,548	3,545	3,716	3,991	3,988
Retained Earnings	7,049	6,550	5,693	4,973	3,849	2,802
Treasury Stock	-	-	-3.76	-42.24	-77.41	-27.76
Comprehensive Income & Other	221.56	324.39	278.95	147.93	68.34	-
Total Common Equity	12,134	11,634	10,726	9,804	8,553	7,481
Minority Interest	785.71	744.32	667.88	642.66	565.39	383.24
Shareholders' Equity	12,920	12,379	11,394	10,447	9,119	7,865
Total Liabilities & Equity	26,835	27,452	27,975	24,137	21,036	17,052
Total Debt	4,276	4,404	5,281	3,798	3,458	3,325
Net Cash (Debt)	5,077	4,694	2,725	1,399	705.02	-252.57
Net Cash Growth	45.82%	72.25%	94.78%	98.44%	-	-
Net Cash Per Share	4.11	3.80	2.21	1.16	0.58	-0.21
Filing Date Shares Outstanding	1,212	1,212	1,212	1,213	1,212	1,208
Total Common Shares Outstanding	1,212	1,212	1,212	1,213	1,212	1,208
Working Capital	5,731	5,073	3,258	859.44	918.95	1,171
Book Value Per Share	10.01	9.60	8.85	8.08	7.05	6.20
Tangible Book Value	6,898	6,388	5,474	4,723	3,887	3,374
Tangible Book Value Per Share	5.69	5.27	4.51	3.89	3.21	2.79
Buildings	-	1,598	1,364	1,291	1,004	683.76
Machinery	-	1,196	1,174	1,001	843.34	722.34
Construction In Progress	-	83.78	228.58	175.12	239.85	358.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.